2022. Combined use of immunohistochemical markers of basal and luminal subtypes in urothelial carcinoma of the bladder: Association with clinicopathological features and outcomes. Clinics. 76, (Mar. 2022), e2587. DOI:https://doi.org/10.6061/clinics/2021/e2587.